Connor, Clark & Lunn Investment Management Ltd. Maravai Lifesciences Holdings, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $21.1 Billion
- Q1 2025
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 316,502 shares of MRVI stock, worth $721,624. This represents 0.0% of its overall portfolio holdings.
Number of Shares
316,502
Previous 447,994
29.35%
Holding current value
$721,624
Previous $2.44 Million
71.36%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding MRVI
# of Institutions
208Shares Held
129MCall Options Held
267KPut Options Held
648K-
Gtcr LLC20.2MShares$45.9 Million4.99% of portfolio
-
12 West Capital Management LP New York, NY12.5MShares$28.5 Million4.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$26.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$22.2 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$19 Million1.13% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $300M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...